Bibliotecas PUC-SP - Busca Integrada

CAR-T cells and BiTEs in solid tumors: challenges and perspectives

Por Julien Edeline, Roch Houot, Aurélien Marabelle, Marion Alcantara
Publicado no Journal of Hematology & Oncology (2021-04-01)

Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?

Por Christophe Maritaz, Sophie Broutin, Nathalie Chaput, Aurélien Marabelle, Angelo Paci
Publicado no Journal of Hematology & Oncology (2022-01-01)

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

Por Laura Rosa Brunet, Thorsten Hagemann, Andrew Gaya, Satvinder Mudan, Aurelien Marabelle
Publicado no OncoImmunology (2016-04-01)

755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy...

Por Aurélien Marabelle, John Mumm, Douglas Orr, Alexander I Spira, Elizabeth C Moser, Deb Kientop
Publicado no Journal for ImmunoTherapy of Cancer (2023-11-01)

A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer

Por Clémence Legoupil, Didier Debieuvre, Aurelien Marabelle, Stefan Michiels, Raïssa Kapso, Benjamin Besse, Julia Bonastre
Publicado no ERJ Open Research (2020-04-01)

Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma

Por Aurélien Marabelle, Laurence Albiges, Angelo Paci, Cécile Dalban, David Combarel, Sophie Broutin, Christophe Maritaz, Louis Blondel
Publicado no Journal for ImmunoTherapy of Cancer (2025-01-01)

In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CA...

Por Béatrice Clémenceau, Sandrine Valsesia-Wittmann, Anne-Catherine Jallas, Régine Vivien, Raphaël Rousseau, Aurélien Marabelle, Christophe Caux, Henri Vié
Publicado no Journal of Immunology Research (2015-01-01)

Repurposing infectious disease vaccines for intratumoral immunotherapy

Por Aurélien Marabelle, Christophe Caux, Ignacio Melero, Alvaro Teijeira, Tala Shekarian, Sandrine Valsesia-Wittmann, Maria Gato, Angela Aznar, Iñaki Etxeberrria
Publicado no Journal for ImmunoTherapy of Cancer (2020-05-01)

Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?

Por Selma Addou, Clémentine Sarkozy, Julien Lazarovici, Stéphane Champiat, Aspasia Stamatoullas, Fabrice Jardin, Vincent Ribrag, Aurélien Marabelle, Jean-Marie Michot
Publicado no Human Vaccines & Immunotherapeutics (2021-10-01)

Organizational Impact of Immunotherapies in Advanced Cancers in France

Por Valentine Grumberg, Christos Chouaïd, Anne-Françoise Gaudin, Christophe Le Tourneau, Aurélien Marabelle, Isabelle Bongiovanni-Delarozière, François-Emery Cotté, Isabelle Borget
Publicado no JCO Global Oncology (2023-08-01)

Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade

Por Olivier Lambotte, Jean-Marie Michot, Stephane Champiat, Francois-Xavier Danlos, Aurélien Marabelle, Romain Guitton, Ariane Laparra, Noemie Chanson, Sabine Messayke
Publicado no Journal for ImmunoTherapy of Cancer (2025-09-01)

315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody

Por Aurélien Marabelle, Carlos Gomez-Roca, Pierre Ferre, Eric Chetaille, Aurelie Petain, Celine Thuilliez, Isabelle Vandenberghe, Francisco Cruzalegui, Asmaa Boudribila, Mariya Pavlyuk
Publicado no Journal for ImmunoTherapy of Cancer (2020-11-01)

316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A

Por Aurélien Marabelle, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Paul Frohna, Christiane Jungels, Norbert Vey, Elena Garralda, Marina Iché
Publicado no Journal for ImmunoTherapy of Cancer (2020-11-01)

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

Por Stephane Champiat, Francois-Xavier Danlos, Aurélien Marabelle, Yohann Loriot, Julia Delahousse, Kaïssa Ouali, Santiago Ponce, Laurent Mathiot, David Combarel, Justin Cagnat, Sophie Broutin
Publicado no Journal for ImmunoTherapy of Cancer (2024-05-01)

484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors

Por Stephane Champiat, Aurélien Marabelle, Aung Naing, Filip Janku, Patricia LoRusso, David Béchard, Elena Garralda, Vladimir Galvao, Peter Grell, Richard Sachse, Joachim Kiemle-Kallee
Publicado no Journal for ImmunoTherapy of Cancer (2021-11-01)

Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice

Por Aurélien Marabelle, Louis Meyblum, Lambros Tselikas, Thierry de Baere, Sandrine Susini, Fréderic Deschamps, Baptiste Bonnet, Céline Chevaleyre, Benoit Jego, Dimitri Kereselidze, Vincent Lebon, Charles Truillet
Publicado no Journal for ImmunoTherapy of Cancer (2023-11-01)

Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy

Por Aurélien Marabelle, Samy Ammari, Eric Deutsch, Michael Farwell, Heiko Schöder, Lawrence H Schwartz, Binsheng Zhao, Laurent Dercle, Jeremy McGale, Shawn Sun, Randy Yeh, Fatima-Zohra Mokrane
Publicado no Journal for ImmunoTherapy of Cancer (2022-09-01)

Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

Por Ben Tran, Richard D. Carvajal, Aurelien Marabelle, Sandip Pravin Patel, Patricia M. LoRusso, Erik Rasmussen, Gloria Juan, Vijay V. Upreti, Courtney Beers, Gataree Ngarmchamnanrith, Patrick Schöffski
Publicado no Journal for ImmunoTherapy of Cancer (2018-09-01)

Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies

Por Aurélien Marabelle, Laurence Zitvogel, Lambros Tselikas, Thierry de Baere, Thomas Isoardo, Sandrine Susini, Karine Ser-Le Roux, Mélanie Polrot, Julien Adam, Mathieu Rouanne, Laurence Moine, Fréderic Deschamps
Publicado no Journal for ImmunoTherapy of Cancer (2020-05-01)

CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy

Por Jean-Marie Michot, Severine Mouraud, Julien Adam, Julien Lazarovici, Camille Bigenwald, Charlotte Rigaud, Lambros Tselikas, Peggy Dartigues, Alina Danu, Amélie Bigorgne, Veronique Minard, David Ghez, Aurélien Marabelle, Laurence Zitvogel, Vincent Ribrag
Publicado no Cancers (2021-10-01)